Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma-Reference-Cited by-同舟云学术

Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma

Published:2017-05-03 Issue:2 Volume:178 Page:196-208
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Dutta Ankit K.¹²^ORCID,Hewett Duncan R.¹²^ORCID,Fink J. Lynn³^ORCID,Grady John P.³^ORCID,Zannettino Andrew C. W.¹²

Affiliation:

1. School of Medicine Adelaide Medical School; Faculty of Health and Medical Sciences; The University of Adelaide; Adelaide SA Australia

2. Cancer Theme; South Australian Health & Medical Research Institute; Adelaide SA Australia

3. The University of Queensland; Diamantina Institute; Woolloongabba QLD Australia

Funder

National Health and Medical Research Council

Leukaemia Foundation

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14649/fullpdf

Reference76 articles.

1. Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma;Abe;International Journal of Hematology,2011

2. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers;Agirre;Genome Research,2015

3. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome;Avet-Loiseau;Cancer Research,1999

4. Darwinian evolution and tiding clones in multiple myeloma;Bahlis;Blood,2012

5. V. Molecular classification and risk stratification of myeloma;Bergsagel;Hematological Oncology,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma;Biomarker Research;2023-03-08

2. Recent Developments of Multiple Myeloma: Analysis and Analytical Modeling Using Real Data;Accounting, Finance, Sustainability, Governance & Fraud: Theory and Application;2023

3. The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma;Frontiers in Oncology;2022-12-20

4. Cancers of the Blood;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13

5. Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study;Hemato;2022-02-22